Playlist

Moscow to Host Large-Scale Days of Turkmen Culture Festival

01 Jun. 16:47

Source

In early June, Moscow will become the center of a major bilateral cultural exchange designed to showcase the vibrant heritage of Turkmenistan to the Russian public. The multi-day cultural forum is jointly organized by the Ministries of Culture of both nations. The event is actively supported by the Embassy of Turkmenistan in the Russian Federation and the federal state cultural agency "Rosconcert."

The artistic program features high-profile performances by leading national ensembles and vocalists at prestigious municipal venues. The inaugural concert is scheduled to take place at the Moscow State Academic Theater "Russkaya Pesnya," showcasing classical folk orchestrations. A subsequent major performance and closing ceremony will be hosted on the stage of the Moscow Theater "Et Cetera."

In addition to theatrical performances, the intercultural exchange will feature extensive art and historical exhibitions. Curated spaces will display unique specimens of Turkmen fine arts, traditional tapestry, and intricate decorative crafts. Visitors will have a rare opportunity to explore authentic customs, national costumes, and structural elements of ancient regional craftsmanship.

The organizing committee stated that all scheduled events are aimed at promoting cross-border mutual understanding, meaning public admission to all concert halls and galleries is entirely free of charge. To manage venue capacities effectively, a mandatory digital pre-registration system has been established for attendees. The cultural showcase marks a key milestone in reinforcing institutional humanitarian ties.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌